Untitled Document
  About prIME Oncology Cases in Non-Small Cell Lung Cancer
 
prIME Oncology invites you to participate in our prIME Cases in Non-Small Cell Lung Cancer (NSCLC) series; a CME-certified series of 3 case studies, each with an expert perspective from internationally renowned thought leaders in lung cancer. Participants will be able to vote on their preferred therapy choice(s) and view the aggregate, real-time results of their peers’ choices. 		 
Treatment Options for Non-Small Cell Lung Cancer in the Second-Line Setting

Treatment Options for Non-Small Cell Lung Cancer in the Second-Line Setting

Edward Kim, MD
M. D. Anderson Cancer Center
Houston, Texas, United States
The Impact of EGFR Mutations in the Management of Advanced Non-Small Cell Lung Cancer

The Impact of EGFR Mutations in the Management of Advanced Non-Small Cell Lung Cancer

Roman Perez-Soler, MD
Montefiore Medical Center
Bronx, New York, United States
Front-Line Treatment of Advanced Non-Small Cell Lung Cancer: Examining Options in EGFR Wildtype Tumors and the Role of Maintenance Therapy

Front-Line Treatment of Advanced Non-Small Cell Lung Cancer: Examining Options in EGFR Wildtype Tumors and the Role of Maintenance Therapy

Mark A. Socinski, MD
UPMC Lung Cancer Center of Excellence
University of Pittsburgh
Pittsburgh, Pennsylvania, United States